Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02637349 · ClinicalTrials.gov registry record · Phase 2
Polaris Oncology Survivor Transition (POST) System
A Phase 2 study, sponsored by Polaris Health Directions.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT02637349: Completed Phase 2 study, sponsored by Polaris Health Directions.
NCT02637349 is a Phase 2 study that has completed, run by Polaris Health Directions. The registered enrollment target is 200 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02637349, a Phase 2 study, has completed, sponsored by Polaris Health Directions.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
The POST's public health impact is likely to be substantial because it will improve cancer survivorship planning, which is currently an important deficiency in cancer care recognized by the Institute of Medicine and the American College of Surgeons. The POST may have many potential benefits for patients such as: 1. improved long-term health outcomes; 2. improved psychosocial outcomes and quality of life; 3. smoother transitions back into old and new life roles; and 4. improved continuity and coordination of care between providers. Most importantly, the POST's influence may reach beyond the patients it directly serves as it could help scientists and health care providers understand the potential benefits of cancer survivorship planning and how to best design and implement survivorship planning when patients are ending treatment for cancer.
Primary Outcome
Quality of life will be measured at baseline and at the follow-ups using the City of Hope Quality of Life measure. Improvement in quality of life is the primary goal of survivorship planning.
Interventions
- BEHAVIORAL POST Intervention
- BEHAVIORAL POST Treatment as Usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2016-11-30 |
| Est. Completion | 2019-08-31 |
| Phase | Phase 2 |
What the finished NCT02637349 record still lists
NCT02637349 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% higher).
The record links to 0 conditions, and to 2 interventions - of which POST Intervention is the first listed.
NCT02637349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02637349 about?
NCT02637349 is a clinical study titled "Polaris Oncology Survivor Transition (POST) System". The POST's public health impact is likely to be substantial because it will improve cancer survivorship planning, which is currently an important deficiency in cancer care recognized by the Institute of Medicine and the American College of Surgeons. The POST may have many potential benefits for pat...
What is the current status of trial NCT02637349?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2016-11-30. Estimated completion is 2019-08-31.
What interventions are being tested in trial NCT02637349?
The interventions under investigation include: POST Intervention (BEHAVIORAL), POST Treatment as Usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT02637349?
This trial is sponsored by Polaris Health Directions, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02637349's enrollment target sits among peer trials
200 304th of 2000 higher than 1,652 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI